What is Eclipse BioInnovations?
Eclipse BioInnovations is at the forefront of RNA genomics, specializing in the development of cutting-edge technology solutions designed to accelerate scientific and medical breakthroughs within the RNA space. The company's proprietary RNA genomics platform is instrumental in creating a suite of advanced genomics products. These products are utilized by a global customer base in the biopharmaceutical and academic sectors, enabling them to generate high-resolution maps of the RNA-interactome. Eclipse BioInnovations consistently pushes the boundaries of RNA genomics through the continuous development of novel products and sophisticated computational biology solutions, thereby supporting RNA researchers worldwide.
How much funding has Eclipse BioInnovations raised?
Eclipse BioInnovations has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Eclipse BioInnovations?
With its substantial backing and a clear focus on large-scale, late-stage funding, Eclipse BioInnovations is strategically positioned for significant expansion and market penetration. The recent major strategic investment suggests a trajectory towards scaling operations, enhancing product development, and potentially exploring new therapeutic applications derived from its RNA genomics platform. The company's ongoing commitment to innovation in RNA genomics indicates a future focused on solidifying its leadership in the biopharma and academic research markets, driving further scientific discovery and medical advancements.
See full Eclipse BioInnovations company page
